FHIR IG Statistics: ValueSet/2.16.840.1.113883.3.464.1003.1247

Resources that use this resource

No resources found

Resources that this resource uses

Narrative

No narrative content found in resource

Source

{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113883.3.464.1003.1247",
  "meta": {
    "versionId": "6",
    "lastUpdated": "2024-01-23T15:25:41.000-05:00",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail": {
        "name": "NCQA PHEMUR Author"
      }
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate": "2025-03-10"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate": "2024-01-10"
    }
  ],
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1247",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113883.3.464.1003.1247"
    }
  ],
  "version": "20240110",
  "name": "MegestrolMedications",
  "title": "Megestrol Medications",
  "status": "active",
  "date": "2024-01-10T01:09:31-05:00",
  "publisher": "NCQA PHEMUR",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "urn:iso:std:iso:3166",
          "code": "US"
        }
      ]
    }
  ],
  "purpose": "(Clinical Focus: The purpose of this value set is to represent concepts for megestrol medications.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent generic, human use, prescribable megestrol and megestrol in combination with other medications.),(Exclusion Criteria: Excludes concepts that represent non-prescribable, branded drugs and excludes concepts that represent components or ingredients.)",
  "compose": {
    "include": [
      {
        "valueSet": [
          "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1255"
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:848f78ae-a239-437c-9a87-bf1d2cf13041",
    "timestamp": "2025-05-23T22:29:44-04:00",
    "total": 4,
    "contains": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "577154",
        "display": "megestrol acetate 125 MG/ML Oral Suspension"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "860215",
        "display": "megestrol acetate 20 MG Oral Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "860221",
        "display": "megestrol acetate 40 MG Oral Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "860225",
        "display": "megestrol acetate 40 MG/ML Oral Suspension"
      }
    ]
  }
}